Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 2
2017 2
2018 2
2019 6
2020 4
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

17 results
Results by year
Filters applied: . Clear all
Page 1
NAD+ metabolism governs the proinflammatory senescence-associated secretome.
Nacarelli T, Lau L, Fukumoto T, Zundell J, Fatkhutdinov N, Wu S, Aird KM, Iwasaki O, Kossenkov AV, Schultz D, Noma KI, Baur JA, Schug Z, Tang HY, Speicher DW, David G, Zhang R. Nacarelli T, et al. Among authors: fatkhutdinov n. Nat Cell Biol. 2019 Mar;21(3):397-407. doi: 10.1038/s41556-019-0287-4. Epub 2019 Feb 18. Nat Cell Biol. 2019. PMID: 30778219 Free PMC article.
EZH2 Inhibition Sensitizes CARM1-High, Homologous Recombination Proficient Ovarian Cancers to PARP Inhibition.
Karakashev S, Fukumoto T, Zhao B, Lin J, Wu S, Fatkhutdinov N, Park PH, Semenova G, Jean S, Cadungog MG, Borowsky ME, Kossenkov AV, Liu Q, Zhang R. Karakashev S, et al. Among authors: fatkhutdinov n. Cancer Cell. 2020 Feb 10;37(2):157-167.e6. doi: 10.1016/j.ccell.2019.12.015. Epub 2020 Jan 30. Cancer Cell. 2020. PMID: 32004442 Free PMC article.
N6-Methylation of Adenosine of FZD10 mRNA Contributes to PARP Inhibitor Resistance.
Fukumoto T, Zhu H, Nacarelli T, Karakashev S, Fatkhutdinov N, Wu S, Liu P, Kossenkov AV, Showe LC, Jean S, Zhang L, Zhang R. Fukumoto T, et al. Among authors: fatkhutdinov n. Cancer Res. 2019 Jun 1;79(11):2812-2820. doi: 10.1158/0008-5472.CAN-18-3592. Epub 2019 Apr 9. Cancer Res. 2019. PMID: 30967398 Free PMC article.
ARID1A promotes genomic stability through protecting telomere cohesion.
Zhao B, Lin J, Rong L, Wu S, Deng Z, Fatkhutdinov N, Zundell J, Fukumoto T, Liu Q, Kossenkov A, Jean S, Cadungog MG, Borowsky ME, Drapkin R, Lieberman PM, Abate-Shen CT, Zhang R. Zhao B, et al. Among authors: fatkhutdinov n. Nat Commun. 2019 Sep 6;10(1):4067. doi: 10.1038/s41467-019-12037-4. Nat Commun. 2019. PMID: 31492885 Free PMC article.
Repurposing Pan-HDAC Inhibitors for ARID1A-Mutated Ovarian Cancer.
Fukumoto T, Park PH, Wu S, Fatkhutdinov N, Karakashev S, Nacarelli T, Kossenkov AV, Speicher DW, Jean S, Zhang L, Wang TL, Shih IM, Conejo-Garcia JR, Bitler BG, Zhang R. Fukumoto T, et al. Among authors: fatkhutdinov n. Cell Rep. 2018 Mar 27;22(13):3393-3400. doi: 10.1016/j.celrep.2018.03.019. Cell Rep. 2018. PMID: 29590609 Free PMC article.
BET Bromodomain Inhibition Synergizes with PARP Inhibitor in Epithelial Ovarian Cancer.
Karakashev S, Zhu H, Yokoyama Y, Zhao B, Fatkhutdinov N, Kossenkov AV, Wilson AJ, Simpkins F, Speicher D, Khabele D, Bitler BG, Zhang R. Karakashev S, et al. Among authors: fatkhutdinov n. Cell Rep. 2017 Dec 19;21(12):3398-3405. doi: 10.1016/j.celrep.2017.11.095. Cell Rep. 2017. PMID: 29262321 Free PMC article.
17 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page